Nebenwirkungen · Keppra
Keppra 250 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 8–9
HOS-090760 · Präparat HOS-084117
8 MedDRA Frequency category SOC Very common Common Uncommon Rare Very rare Infections and Nasopharyngit Infection infestations is Blood and Thrombocytop Pancytopenia, lymphatic enia, neutropenia, system leukopenia agranulocytosis disorders Immune Drug reaction system with disorders eosinophilia and systemic symptoms (DRESS)(1), Hypersensitivity (including angioedema and anaphylaxis) Metabolism Anorexia Weight Hyponatraemia and nutrition decreased, disorders weight increase Psychiatric Depression, Suicide Completed Obsessive disorders hostility/ attempt, suicide, compulsive aggression, suicidal personality disorder(2) anxiety, ideation, disorder, insomnia, psychotic thinking nervousness disorder, abnormal, /irritability abnormal delirium behaviour, hallucination, anger, confusional state, panic attack, affect lability/mood swings, agitation Nervous Somnolence, Convulsion, Amnesia, Choreoathetosis, system headache balance memory dyskinesia, disorders disorder, impairment, hyperkinesia, dizziness, coordination gait disturbance, lethargy, abnormal/ataxi encephalopathy, tremor a, paraesthesia, seizures disturbance in aggravated, attention Neuroleptic malignant syndrome(3) Eye disorders Diplopia, vision blurred Ear and Vertigo labyrinth disorders Cardiac Electrocardiogra disorders m QT prolonged
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-04-01T12:51:00Z · SHA-256 0c9c2dbe2cf9e6cd5c8f5c1f489027f4a1e9204a5531ad8b866e3bc0e64b2e72 · Passage ddd2668220d3fe074ce48af45adf592f1be9a4e06a6dc33df11cc4084aa92ff3 · Zeichen 1194–5042 im Abschnitt